Global and India Biosimilar Insulin Market Report & Forecast 2023-2029

and India Biosimilar Insulin Market

Biosimilar insulin is a biological copy of an original insulin and there is increasing interest in developing and using them. Biosimilar insulins (hereafter called biosimilars or follow-on biologics) are designed to be highly similar to the original, or reference, insulin product described in a patent. They are analogous to generic versions of small-molecule drugs and are developed by companies other than the reference product's patent holder. Producers of biosimilars use manufacturing techniques that are similar, but likely not identical to, those used by the original patent holder. Thus, although a biosimilar and its reference insulin product will have the same amino acid sequence, they may differ slightly in their more subtle molecular characteristics and clinical profiles.

In India, the Biosimilar Insulin revenue is expected to grow from US$ million in 2022 to US$ million by 2029, at a CAGR of % during the forecast period (2023-2029).

Global Biosimilar Insulin key players include Biocon, Gan&Lee, Wockhardt, Eli Lilly, Sanofi etc. Global top three players hold a share over 70%. India is the largest market, with a share about 30%, followed by Southeast Asia and China, both have a share about 40 percent

This report focuses on global and India Biosimilar Insulin market, also covers the segmentation data of other regions in regional level and county level.

India is now the world’s most populous country. According to IMF (its July update to its World Economic Outlook), India’s GDP growth is projected at 6.1% in 2023, powered by domestic investment. First and foremost, the key factor in India's rapid economic growth is the huge supply and demand from a large population base. Demand and supply sides working in both directions to support India's economic stability.

India is a market full of opportunities, and the demand for Biosimilar Insulin will continue to grow rapidly in the future.

Global Biosimilar Insulin Scope and Market Size

Biosimilar Insulin market is segmented in regional and country, by players, by type and by distribution channel. Companies, stakeholders, and other participants in the global Biosimilar Insulin market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by type and by distribution channel for the period 2018-2029.

For India market, this report focuses on the Biosimilar Insulin market size by players, by Type and by Distribution Channel, for the period 2018-2029. The key players include the global and local players, which play important roles in India.

Scope of and India Biosimilar Insulin Market Report

1.1 Biosimilar Insulin Product Introduction

1.2 Global Biosimilar Insulin Outlook 2018 VS 2022 VS 2029

1.2.1 Global Biosimilar Insulin Sales in US$ Million for the Year 2018-2029

1.2.2 Global Biosimilar Insulin Sales in Volume for the Year 2018-2029

1.3 India Biosimilar Insulin Outlook 2018 VS 2022 VS 2029

1.3.1 India Biosimilar Insulin Sales in US$ Million for the Year 2018-2029

1.3.2 India Biosimilar Insulin Sales in Volume for the Year 2018-2029

1.4 Biosimilar Insulin Market Size, India VS Global, 2018 VS 2022 VS 2029

1.4.1 The Market Share of India Biosimilar Insulin in Global, 2018 VS 2022 VS 2029

1.4.2 The Growth Rate of Biosimilar Insulin Market Size, India VS Global, 2018 VS 2022 VS 2029

1.5 Biosimilar Insulin Market Dynamics

1.5.1 Biosimilar Insulin Industry Trends

1.5.2 Biosimilar Insulin Market Drivers

1.5.3 Biosimilar Insulin Market Challenges

1.5.4 Biosimilar Insulin Market Restraints

1.6 Study Objectives

1.7 Years Considered

1.8 Years Considered

2.1 Biosimilar Insulin Market Segment by Type

2.1.1 Biosimilar Insulin Glargine

2.1.2 Biosimilar Insulin Lispro

2.1.3 Other

2.2 Global Biosimilar Insulin Market Size by Type

2.2.1 Global Biosimilar Insulin Sales in Value, by Type (2018, 2022 & 2029)

2.2.2 Global Biosimilar Insulin Sales in Volume, by Type (2018, 2022 & 2029)

2.2.3 Global Biosimilar Insulin Average Selling Price (ASP) by Type (2018, 2022 & 2029)

2.3 India Biosimilar Insulin Market Size by Type

2.3.1 India Biosimilar Insulin Sales in Value, by Type (2018, 2022 & 2029)

2.3.2 India Biosimilar Insulin Sales in Volume, by Type (2018, 2022 & 2029)

2.3.3 India Biosimilar Insulin Average Selling Price (ASP) by Type (2018, 2022 & 2029)

3.1 Biosimilar Insulin Market Segment by Distribution Channel

3.1.1 Hospital

3.1.2 Retail Pharmacy

3.1.3 Others

3.2 Global Biosimilar Insulin Market Size by Distribution Channel

3.2.1 Global Biosimilar Insulin Sales in Value, by Distribution Channel (2018, 2022 & 2029)

3.2.2 Global Biosimilar Insulin Sales in Volume, by Distribution Channel (2018, 2022 & 2029)

3.3.3 Global Biosimilar Insulin Average Selling Price (ASP) by Distribution Channel (2018, 2022 & 2029)

3.3 India Biosimilar Insulin Market Size by Distribution Channel

3.3.1 India Biosimilar Insulin Sales in Value, by Distribution Channel (2018, 2022 & 2029)

3.3.2 India Biosimilar Insulin Sales in Volume, by Distribution Channel (2018, 2022 & 2029)

3.3.3 India Biosimilar Insulin Average Selling Price (ASP) by Distribution Channel (2018, 2022 & 2029)

4.1 Global Biosimilar Insulin Market Size by Company

4.1.1 Global Key Manufacturers of Biosimilar Insulin, Ranked by Revenue (2022)

4.1.2 Global Biosimilar Insulin Revenue by Manufacturer (2018-2023)

4.1.3 Global Biosimilar Insulin Sales by Manufacturer (2018-2023)

4.1.4 Global Biosimilar Insulin Price by Manufacturer (2018-2023)

4.2 Global Biosimilar Insulin Concentration Ratio (CR)

4.2.1 Biosimilar Insulin Market Concentration Ratio (CR)

4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Biosimilar Insulin in 2022

4.2.3 Global Biosimilar Insulin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

4.3 Global Key Manufacturers of Biosimilar Insulin, Manufacturing Base Distribution and Headquarters

4.4 Global Key Manufacturers of Biosimilar Insulin, Product Offered and Application

4.5 Global Key Manufacturers of Biosimilar Insulin, Date of Enter into This Industry

4.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4.7 India Biosimilar Insulin Market Size by Company

4.7.1 Key Players of Biosimilar Insulin in India, Ranked by Revenue (2022)

4.7.2 India Biosimilar Insulin Revenue by Players (2018-2023)

4.7.3 India Biosimilar Insulin Sales by Players (2018-2023)

5.1 Global Biosimilar Insulin Market Size by Region: 2018 VS 2022 VS 2029

5.2 Global Biosimilar Insulin Market Size in Volume by Region (2018-2029)

5.2.1 Global Biosimilar Insulin Sales in Volume by Region: 2018-2023

5.2.2 Global Biosimilar Insulin Sales in Volume Forecast by Region (2024-2029)

5.3 Global Biosimilar Insulin Market Size in Value by Region (2018-2029)

5.3.1 Global Biosimilar Insulin Sales in Value by Region: 2018-2023

5.3.2 Global Biosimilar Insulin Sales in Value by Region: 2024-2029

6.1 Americas Biosimilar Insulin Market Size YoY Growth 2018-2029

6.2 Americas Biosimilar Insulin Sales in Volume, by Type (2018, 2022 & 2029)

6.3 Americas Biosimilar Insulin Sales in Volume, by Distribution Channel (2018, 2022 & 2029)

6.4 Americas Biosimilar Insulin Market Facts & Figures by Country (2018, 2022 & 2029)

6.4.1 Americas Biosimilar Insulin Sales in Value by Country (2018, 2022 & 2029)

6.4.2 Americas Biosimilar Insulin Sales in Volume by Country (2018, 2022 & 2029)

6.4.3 United States

6.4.4 Canada

6.4.5 Mexico

6.4.6 Brazil

7.1 EMEA Biosimilar Insulin Market Size YoY Growth 2018-2029

7.2 EMEA Biosimilar Insulin Sales in Volume, by Type (2018, 2022 & 2029)

7.3 EMEA Biosimilar Insulin Sales in Volume, by Distribution Channel (2018, 2022 & 2029)

7.4 EMEA Biosimilar Insulin Market Facts & Figures by Country (2018, 2022 & 2029)

7.4.1 EMEA Biosimilar Insulin Sales in Value by Country (2018, 2022 & 2029)

7.4.2 EMEA Biosimilar Insulin Sales in Volume by Country (2018, 2022 & 2029)

7.4.3 Europe

7.4.4 Middle East

7.4.5 Africa

8.1 China Biosimilar Insulin Market Size YoY Growth 2018-2029

8.2 China Biosimilar Insulin Sales in Volume, by Type (2018, 2022 & 2029)

8.3 China Biosimilar Insulin Sales in Volume, by Distribution Channel (2018, 2022 & 2029)

9.1 APAC Biosimilar Insulin Market Size YoY Growth 2018-2029

9.2 APAC Biosimilar Insulin Sales in Volume, by Type (2018, 2022 & 2029)

9.3 APAC Biosimilar Insulin Sales in Volume, by Distribution Channel (2018, 2022 & 2029)

9.4 APAC Biosimilar Insulin Market Facts & Figures by Region (2018, 2022 & 2029)

9.4.1 APAC Biosimilar Insulin Sales in Value by Region (2018, 2022 & 2029)

9.4.2 APAC Biosimilar Insulin Sales in Volume by Region (2018, 2022 & 2029)

9.4.3 Japan

9.4.4 South Korea

9.4.5 China Taiwan

9.4.6 Southeast Asia

9.4.7 India

10.1 Eli Lilly

10.1.1 Eli Lilly Company Information

10.1.2 Eli Lilly Description and Business Overview

10.1.3 Eli Lilly Biosimilar Insulin Sales, Revenue and Gross Margin (2018-2023)

10.1.4 Eli Lilly Biosimilar Insulin Products Offered

10.1.5 Eli Lilly Recent Development

10.2 Sanofi

10.2.1 Sanofi Company Information

10.2.2 Sanofi Description and Business Overview

10.2.3 Sanofi Biosimilar Insulin Sales, Revenue and Gross Margin (2018-2023)

10.2.4 Sanofi Biosimilar Insulin Products Offered

10.2.5 Sanofi Recent Development

10.3 Gan&Lee

10.3.1 Gan&Lee Company Information

10.3.2 Gan&Lee Description and Business Overview

10.3.3 Gan&Lee Biosimilar Insulin Sales, Revenue and Gross Margin (2018-2023)

10.3.4 Gan&Lee Biosimilar Insulin Products Offered

10.3.5 Gan&Lee Recent Development

10.4 Tonghua Dongbao

10.4.1 Tonghua Dongbao Company Information

10.4.2 Tonghua Dongbao Description and Business Overview

10.4.3 Tonghua Dongbao Biosimilar Insulin Sales, Revenue and Gross Margin (2018-2023)

10.4.4 Tonghua Dongbao Biosimilar Insulin Products Offered

10.4.5 Tonghua Dongbao Recent Development

10.5 United Laboratory

10.5.1 United Laboratory Company Information

10.5.2 United Laboratory Description and Business Overview

10.5.3 United Laboratory Biosimilar Insulin Sales, Revenue and Gross Margin (2018-2023)

10.5.4 United Laboratory Biosimilar Insulin Products Offered

10.5.5 United Laboratory Recent Development

10.6 Geropharm

10.6.1 Geropharm Company Information

10.6.2 Geropharm Description and Business Overview

10.6.3 Geropharm Biosimilar Insulin Sales, Revenue and Gross Margin (2018-2023)

10.6.4 Geropharm Biosimilar Insulin Products Offered

10.6.5 Geropharm Recent Development

10.7 Biocon

10.7.1 Biocon Company Information

10.7.2 Biocon Description and Business Overview

10.7.3 Biocon Biosimilar Insulin Sales, Revenue and Gross Margin (2018-2023)

10.7.4 Biocon Biosimilar Insulin Products Offered

10.7.5 Biocon Recent Development

10.8 Wockhardt

10.8.1 Wockhardt Company Information

10.8.2 Wockhardt Description and Business Overview

10.8.3 Wockhardt Biosimilar Insulin Sales, Revenue and Gross Margin (2018-2023)

10.8.4 Wockhardt Biosimilar Insulin Products Offered

10.8.5 Wockhardt Recent Development

11.1 Biosimilar Insulin Industry Chain Analysis

11.2 Biosimilar Insulin Key Raw Materials

11.2.1 Key Raw Materials

11.2.2 Raw Materials Key Suppliers

11.3 Biosimilar Insulin Production Mode & Process

11.4 Biosimilar Insulin Sales and Marketing

11.4.1 Biosimilar Insulin Sales Channels

11.4.2 Biosimilar Insulin Distributors

11.5 Biosimilar Insulin Customers

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Author Details

13.3 Disclaimer

List of Tables

    Table 1. Biosimilar Insulin CAGR in Value, India VS Global, 2018 VS 2022 VS 2029

    Table 2. Biosimilar Insulin Market Trends

    Table 3. Biosimilar Insulin Market Drivers

    Table 4. Biosimilar Insulin Market Challenges

    Table 5. Biosimilar Insulin Market Restraints

    Table 6. Global Biosimilar Insulin Sales Growth Rate (CAGR) by Type: 2018 VS 2022 VS 2029 (US$ Million)

    Table 7. India Biosimilar Insulin Sales Growth Rate (CAGR) by Type: 2018 VS 2022 VS 2029 (US$ Million)

    Table 8. Global Biosimilar Insulin Sales Growth Rate (CAGR) by Distribution Channel: 2018 VS 2022 VS 2029 (US$ Million)

    Table 9. India Biosimilar Insulin Sales Growth Rate (CAGR) by Distribution Channel: 2018 VS 2022 VS 2029 (US$ Million)

    Table 10. Global Key Manufacturers of Biosimilar Insulin, Ranked by Revenue (2022) & (US$ Million)

    Table 11. Global Biosimilar Insulin Revenue by Manufacturer, (US$ Million), 2018-2023

    Table 12. Global Biosimilar Insulin Revenue Share by Manufacturer, 2018-2023

    Table 13. Global Biosimilar Insulin Sales by Manufacturer, (K Unit), 2018-2023

    Table 14. Global Biosimilar Insulin Sales Share by Manufacturer, 2018-2023

    Table 15. Global Biosimilar Insulin Price by Manufacturer (2018-2023) & (US$/Unit)

    Table 16. Global Biosimilar Insulin Manufacturers Market Concentration Ratio (CR5 and HHI)

    Table 17. Global Biosimilar Insulin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biosimilar Insulin as of 2022)

    Table 18. Global Key Manufacturers of Biosimilar Insulin, Manufacturing Base Distribution and Headquarters

    Table 19. Global Key Manufacturers of Biosimilar Insulin, Product Offered and Application

    Table 20. Global Key Manufacturers of Biosimilar Insulin, Date of Enter into This Industry

    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans

    Table 22. Key Players of Biosimilar Insulin in India, Ranked by Revenue (2022) & (US$ million)

    Table 23. India Biosimilar Insulin Revenue by Players, (US$ Million), (2018-2023)

    Table 24. India Biosimilar Insulin Revenue Share by Players, (2018-2023)

    Table 25. India Biosimilar Insulin Sales by Players, (K Unit), (2018-2023)

    Table 26. India Biosimilar Insulin Sales Share by Players, (2018-2023)

    Table 27. Global Biosimilar Insulin Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 28. Global Biosimilar Insulin Sales in Volume by Region (2018-2023) & (K Unit)

    Table 29. Global Biosimilar Insulin Sales in Volume Forecast by Region (2024-2029) & (K Unit)

    Table 30. Global Biosimilar Insulin Sales in Value by Region (2018-2023) & (US$ Million)

    Table 31. Global Biosimilar Insulin Sales in Value Forecast by Region (2024-2029) & (US$ Million)

    Table 32. Americas Biosimilar Insulin Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 33. Americas Biosimilar Insulin Sales in Value by Country (2018-2023) & (US$ Million)

    Table 34. Americas Biosimilar Insulin Sales in Value by Country (2024-2029) & (US$ Million)

    Table 35. Americas Biosimilar Insulin Sales in Volume by Country (2018-2023) & (K Unit)

    Table 36. Americas Biosimilar Insulin Sales in Volume by Country (2024-2029) & (K Unit)

    Table 37. EMEA Biosimilar Insulin Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 38. EMEA Biosimilar Insulin Sales in Value by Country (2018-2023) & (US$ Million)

    Table 39. EMEA Biosimilar Insulin Sales in Value by Country (2024-2029) & (US$ Million)

    Table 40. EMEA Biosimilar Insulin Sales in Volume by Country (2018-2023) & (K Unit)

    Table 41. EMEA Biosimilar Insulin Sales in Volume by Country (2024-2029) & (K Unit)

    Table 42. APAC Biosimilar Insulin Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 43. APAC Biosimilar Insulin Sales in Value by Country (2018-2023) & (US$ Million)

    Table 44. APAC Biosimilar Insulin Sales in Value by Country (2024-2029) & (US$ Million)

    Table 45. APAC Biosimilar Insulin Sales in Volume by Country (2018-2023) & (K Unit)

    Table 46. APAC Biosimilar Insulin Sales in Volume by Country (2024-2029) & (K Unit)

    Table 47. Eli Lilly Company Information

    Table 48. Eli Lilly Description and Business Overview

    Table 49. Eli Lilly Biosimilar Insulin Sales (K Unit), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 50. Eli Lilly Biosimilar Insulin Product

    Table 51. Eli Lilly Recent Development

    Table 52. Sanofi Company Information

    Table 53. Sanofi Description and Business Overview

    Table 54. Sanofi Biosimilar Insulin Sales (K Unit), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 55. Sanofi Biosimilar Insulin Product

    Table 56. Sanofi Recent Development

    Table 57. Gan&Lee Company Information

    Table 58. Gan&Lee Description and Business Overview

    Table 59. Gan&Lee Biosimilar Insulin Sales (K Unit), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 60. Gan&Lee Biosimilar Insulin Product

    Table 61. Gan&Lee Recent Development

    Table 62. Tonghua Dongbao Company Information

    Table 63. Tonghua Dongbao Description and Business Overview

    Table 64. Tonghua Dongbao Biosimilar Insulin Sales (K Unit), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 65. Tonghua Dongbao Biosimilar Insulin Product

    Table 66. Tonghua Dongbao Recent Development

    Table 67. United Laboratory Company Information

    Table 68. United Laboratory Description and Business Overview

    Table 69. United Laboratory Biosimilar Insulin Sales (K Unit), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 70. United Laboratory Biosimilar Insulin Product

    Table 71. United Laboratory Recent Development

    Table 72. Geropharm Company Information

    Table 73. Geropharm Description and Business Overview

    Table 74. Geropharm Biosimilar Insulin Sales (K Unit), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 75. Geropharm Biosimilar Insulin Product

    Table 76. Geropharm Recent Development

    Table 77. Biocon Company Information

    Table 78. Biocon Description and Business Overview

    Table 79. Biocon Biosimilar Insulin Sales (K Unit), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 80. Biocon Biosimilar Insulin Product

    Table 81. Biocon Recent Development

    Table 82. Wockhardt Company Information

    Table 83. Wockhardt Description and Business Overview

    Table 84. Wockhardt Biosimilar Insulin Sales (K Unit), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 85. Wockhardt Biosimilar Insulin Product

    Table 86. Wockhardt Recent Development

    Table 87. Key Raw Materials Lists

    Table 88. Raw Materials Key Suppliers Lists

    Table 89. Biosimilar Insulin Customers List

    Table 90. Biosimilar Insulin Distributors List

    Table 91. Research Programs/Design for This Report

    Table 92. Key Data Information from Secondary Sources

    Table 93. Key Data Information from Primary Sources

List of Figures

    Figure 1. Biosimilar Insulin Product Picture

    Figure 2. Global Biosimilar Insulin Revenue, (US$ Million), 2018 VS 2022 VS 2029

    Figure 3. Global Biosimilar Insulin Market Size 2018-2029 (US$ Million)

    Figure 4. Global Biosimilar Insulin Sales 2018-2029 (K Unit)

    Figure 5. India Biosimilar Insulin Revenue, (US$ Million), 2018 VS 2022 VS 2029

    Figure 6. India Biosimilar Insulin Market Size 2018-2029 (US$ Million)

    Figure 7. India Biosimilar Insulin Sales 2018-2029 (K Unit)

    Figure 8. India Biosimilar Insulin Market Share in Global, in Value (US$ Million) 2018-2029

    Figure 9. India Biosimilar Insulin Market Share in Global, in Volume (K Unit) 2018-2029

    Figure 10. Biosimilar Insulin Report Years Considered

    Figure 11. Product Picture of Biosimilar Insulin Glargine

    Figure 12. Product Picture of Biosimilar Insulin Lispro

    Figure 13. Product Picture of Other

    Figure 14. Global Biosimilar Insulin Market Share by Type in 2022 & 2029

    Figure 15. Global Biosimilar Insulin Sales in Value by Type (2018-2029) & (US$ Million)

    Figure 16. Global Biosimilar Insulin Sales Market Share in Value by Type (2018-2029)

    Figure 17. Global Biosimilar Insulin Sales by Type (2018-2029) & (K Unit)

    Figure 18. Global Biosimilar Insulin Sales Market Share in Volume by Type (2018-2029)

    Figure 19. Global Biosimilar Insulin Price by Type (2018-2029) & (US$/Unit)

    Figure 20. India Biosimilar Insulin Market Share by Type in 2022 & 2029

    Figure 21. India Biosimilar Insulin Sales in Value by Type (2018-2029) & (US$ Million)

    Figure 22. India Biosimilar Insulin Sales Market Share in Value by Type (2018-2029)

    Figure 23. India Biosimilar Insulin Sales by Type (2018-2029) & (K Unit)

    Figure 24. India Biosimilar Insulin Sales Market Share in Volume by Type (2018-2029)

    Figure 25. India Biosimilar Insulin Price by Type (2018-2029) & (US$/Unit)

    Figure 26. Product Picture of Hospital

    Figure 27. Product Picture of Retail Pharmacy

    Figure 28. Product Picture of Others

    Figure 29. Global Biosimilar Insulin Market Share by Distribution Channel in 2022 & 2029

    Figure 30. Global Biosimilar Insulin Sales in Value by Distribution Channel (2018-2029) & (US$ Million)

    Figure 31. Global Biosimilar Insulin Sales Market Share in Value by Distribution Channel (2018-2029)

    Figure 32. Global Biosimilar Insulin Sales by Distribution Channel (2018-2029) & (K Unit)

    Figure 33. Global Biosimilar Insulin Sales Market Share in Volume by Distribution Channel (2018-2029)

    Figure 34. Global Biosimilar Insulin Price by Distribution Channel (2018-2029) & (US$/Unit)

    Figure 35. India Biosimilar Insulin Market Share by Distribution Channel in 2022 & 2029

    Figure 36. India Biosimilar Insulin Sales in Value by Distribution Channel (2018-2029) & (US$ Million)

    Figure 37. India Biosimilar Insulin Sales Market Share in Value by Distribution Channel (2018-2029)

    Figure 38. India Biosimilar Insulin Sales by Distribution Channel (2018-2029) & (K Unit)

    Figure 39. India Biosimilar Insulin Sales Market Share in Volume by Distribution Channel (2018-2029)

    Figure 40. India Biosimilar Insulin Price by Distribution Channel (2018-2029) & (US$/Unit)

    Figure 41. Americas Biosimilar Insulin Sales in Volume Growth Rate 2018-2029 (K Unit)

    Figure 42. Americas Biosimilar Insulin Sales in Value Growth Rate 2018-2029 (US$ Million)

    Figure 43. Americas Biosimilar Insulin Sales by Type (2018-2029) & (K Unit)

    Figure 44. Americas Biosimilar Insulin Sales Market Share in Volume by Type (2018-2029)

    Figure 45. Americas Biosimilar Insulin Sales by Distribution Channel (2018-2029) & (K Unit)

    Figure 46. Americas Biosimilar Insulin Sales Market Share in Volume by Distribution Channel (2018-2029)

    Figure 47. United States Biosimilar Insulin Sales in Value Growth Rate (2018-2029) & (US$ Million)

    Figure 48. Canada Biosimilar Insulin Sales in Value Growth Rate (2018-2029) & (US$ Million)

    Figure 49. Mexico Biosimilar Insulin Sales in Value Growth Rate (2018-2029) & (US$ Million)

    Figure 50. Brazil Biosimilar Insulin Sales in Value Growth Rate (2018-2029) & (US$ Million)

    Figure 51. EMEA Biosimilar Insulin Sales in Volume Growth Rate 2018-2029 (K Unit)

    Figure 52. EMEA Biosimilar Insulin Sales in Value Growth Rate 2018-2029 (US$ Million)

    Figure 53. EMEA Biosimilar Insulin Sales by Type (2018-2029) & (K Unit)

    Figure 54. EMEA Biosimilar Insulin Sales Market Share in Volume by Type (2018-2029)

    Figure 55. EMEA Biosimilar Insulin Sales by Distribution Channel (2018-2029) & (K Unit)

    Figure 56. EMEA Biosimilar Insulin Sales Market Share in Volume by Distribution Channel (2018-2029)

    Figure 57. Europe Biosimilar Insulin Sales in Value Growth Rate (2018-2029) & (US$ Million)

    Figure 58. Middle East Biosimilar Insulin Sales in Value Growth Rate (2018-2029) & (US$ Million)

    Figure 59. Africa Biosimilar Insulin Sales in Value Growth Rate (2018-2029) & (US$ Million)

    Figure 60. China Biosimilar Insulin Sales in Volume Growth Rate 2018-2029 (K Unit)

    Figure 61. China Biosimilar Insulin Sales in Value Growth Rate 2018-2029 (US$ Million)

    Figure 62. China Biosimilar Insulin Sales by Type (2018-2029) & (K Unit)

    Figure 63. China Biosimilar Insulin Sales Market Share in Volume by Type (2018-2029)

    Figure 64. China Biosimilar Insulin Sales by Distribution Channel (2018-2029) & (K Unit)

    Figure 65. China Biosimilar Insulin Sales Market Share in Volume by Distribution Channel (2018-2029)

    Figure 66. APAC Biosimilar Insulin Sales in Volume Growth Rate 2018-2029 (K Unit)

    Figure 67. APAC Biosimilar Insulin Sales in Value Growth Rate 2018-2029 (US$ Million)

    Figure 68. APAC Biosimilar Insulin Sales by Type (2018-2029) & (K Unit)

    Figure 69. APAC Biosimilar Insulin Sales Market Share in Volume by Type (2018-2029)

    Figure 70. APAC Biosimilar Insulin Sales by Distribution Channel (2018-2029) & (K Unit)

    Figure 71. APAC Biosimilar Insulin Sales Market Share in Volume by Distribution Channel (2018-2029)

    Figure 72. Japan Biosimilar Insulin Sales in Value Growth Rate (2018-2029) & (US$ Million)

    Figure 73. South Korea Biosimilar Insulin Sales in Value Growth Rate (2018-2029) & (US$ Million)

    Figure 74. China Taiwan Biosimilar Insulin Sales in Value Growth Rate (2018-2029) & (US$ Million)

    Figure 75. Southeast Asia Biosimilar Insulin Sales in Value Growth Rate (2018-2029) & (US$ Million)

    Figure 76. India Biosimilar Insulin Sales in Value Growth Rate (2018-2029) & (US$ Million)

    Figure 77. Biosimilar Insulin Value Chain

    Figure 78. Biosimilar Insulin Production Process

    Figure 79. Channels of Distribution

    Figure 80. Distributors Profiles

    Figure 81. Bottom-up and Top-down Approaches for This Report

    Figure 82. Data Triangulation

    Figure 83. Key Executives Interviewed